ATO (Arsenic Trioxide) Effects on Promyelocytic Leukemia Nuclear Bodies Reveals Antiviral Intervention Capacity

ATO (Arsenic Trioxide) Effects on Promyelocytic Leukemia Nuclear Bodies Reveals Antiviral Intervention Capacity

Abstract Human adenoviruses (HAdV) are associated with clinical symptoms such as gastroenteritis, keratoconjunctivitis, pneumonia, hepatitis, and encephalitis. In the absence of protective immunity, as in allogeneic bone marrow transplant patients, HAdV infections can become lethal. Alarmingly, vari...

Full description

Bibliographic Details
Main Authors: Samuel Hofmann, Julia Mai, Sawinee Masser, Peter Groitl, Alexander Herrmann, Thomas Sternsdorf, Ruth Brack‐Werner, Sabrina Schreiner
Format: Article
Language:English
Published: Wiley 2020-04-01
Series:Advanced Science
Subjects:
antivirals
arsenic
human adenoviruses
promyelocytic leukemia nuclear bodies
small ubiquitin‐like modifiers (SUMO)
Online Access:https://doi.org/10.1002/advs.201902130

Internet

https://doi.org/10.1002/advs.201902130

Similar Items